Drug development
Pliant Therapeutics develops medicines that aim to treat fibrosis and other diseases that cause tissue scarring. The company runs its own research and clinical trials to move drug candidates forward, and it may also part...
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Pliant Therapeutics is a biotechnology company that develops drug candidates for fibrotic diseases, where the body makes too much scar tissue in organs such as the lungs. Its main focus has been on medicines that block integrins, proteins that help drive the scarring process. The company is still in the drug-development stage, so it does not sell a commercial medicine yet.
Pliant’s work is aimed at patients with serious diseases like pulmonary fibrosis, along with the doctors and hospitals that run clinical trials for these treatments. The company spends most of its time and capital on research, testing, and clinical studies rather than manufacturing or selling products. If a candidate medicine succeeds, it could be sold directly or through a partner to physicians treating these patients.
The company makes money mainly through collaboration deals, licensing arrangements, and related research payments tied to its drug programs, with the longer-term goal of earning product sales or royalties if a medicine is approved. What makes its business different is that it is focused on a narrow but difficult class of diseases where the market depends on getting new drugs through years of testing and regulatory review before any commercial sales begin.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more